ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,376.51
0.95%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tharimmune Inc (THAR)

  7. Tharimmune Inc (THAR) News

Tharimmune (THAR)

Tharimmune Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THAR
DateTimeSourceHeadlineSymbolCompany
09/05/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THARTharimmune Inc
11/03/202420:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:THARTharimmune Inc
11/03/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
23/02/202413:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:THARTharimmune Inc
08/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
12/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
11/12/202311:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:THARTharimmune Inc
27/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
17/11/202322:24Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:THARTharimmune Inc
17/11/202321:22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:THARTharimmune Inc
17/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
16/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
10/11/202300:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THARTharimmune Inc
10/11/202300:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THARTharimmune Inc
07/11/202322:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THARTharimmune Inc
07/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
07/11/202317:29Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:THARTharimmune Inc
06/11/202322:12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:THARTharimmune Inc
02/11/202320:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:THARTharimmune Inc
24/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
29/09/202321:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:THARTharimmune Inc
 Showing the most relevant articles for your search:NASDAQ:THAR

Your Recent History

NASDAQ
NCIT
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved